View in EDS HTML Full Text PDF Full Text

Post marketing safety surveillance of atezolizumab based on a retrospective analysis of the FDA adverse events reporting system (FAERS).

Saved in:
Bibliographic Details
Title: Post marketing safety surveillance of atezolizumab based on a retrospective analysis of the FDA adverse events reporting system (FAERS).
Authors: Zhang, Gan1,2 (AUTHOR), Yu, Danfeng3 (AUTHOR), Pan, Huan4 (AUTHOR), Liu, Jiong1,2 (AUTHOR), Wang, Ruling1,2 (AUTHOR), Wan, Yunyan1,2 (AUTHOR), Zhou, Wuhua1,2 (AUTHOR) ministerwuhua@163.com, Wang, Huaxiang1,2 (AUTHOR) whx@taihehospital.com
Source: Scientific Reports. 11/26/2025, Vol. 15 Issue 1, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 189635214
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Post marketing safety surveillance of atezolizumab based on a retrospective analysis of the FDA adverse events reporting system (FAERS).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Zhang%2C+Gan%22">Zhang, Gan</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yu%2C+Danfeng%22">Yu, Danfeng</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pan%2C+Huan%22">Pan, Huan</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Jiong%22">Liu, Jiong</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Ruling%22">Wang, Ruling</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wan%2C+Yunyan%22">Wan, Yunyan</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Wuhua%22">Zhou, Wuhua</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> ministerwuhua@163.com</i><br /><searchLink fieldCode="AR" term="%22Wang%2C+Huaxiang%22">Wang, Huaxiang</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> whx@taihehospital.com</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Scientific+Reports%22">Scientific Reports</searchLink>. 11/26/2025, Vol. 15 Issue 1, p1-12. 12p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189635214
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41598-025-26340-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 1
    Titles:
      – TitleFull: Post marketing safety surveillance of atezolizumab based on a retrospective analysis of the FDA adverse events reporting system (FAERS).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhang, Gan
      – PersonEntity:
          Name:
            NameFull: Yu, Danfeng
      – PersonEntity:
          Name:
            NameFull: Pan, Huan
      – PersonEntity:
          Name:
            NameFull: Liu, Jiong
      – PersonEntity:
          Name:
            NameFull: Wang, Ruling
      – PersonEntity:
          Name:
            NameFull: Wan, Yunyan
      – PersonEntity:
          Name:
            NameFull: Zhou, Wuhua
      – PersonEntity:
          Name:
            NameFull: Wang, Huaxiang
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 11
              Text: 11/26/2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 20452322
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Scientific Reports
              Type: main
ResultId 1